Ftse Mib
38.815,10
0,41%
DAX
23.059,39
0,52%
S&P 500
5.638,94
2,13%
NASDAQ
17.754,09
2,61%
Bitcoin
83.249,79
0,85%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ CASI Pharmaceuticals Inc (CASI) CASI Pharmaceuticals Inc (CASI) Notizie

CASI Pharmaceuticals Inc

CASI
2,225
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 09:00:03
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/2/202514:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/1/202514:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/1/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
26/12/202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/12/202422:16EDGAR2Form F-3/A - Registration statement by foreign private..
20/12/202423:26EDGAR2Form F-3 - Registration statement by foreign private issuers
16/12/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202413:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/9/202414:00PRNUSCASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C...
29/8/202414:00EDGAR2Form F-3/A - Registration statement by foreign private..
16/8/202423:01EDGAR2Form F-3 - Registration statement by foreign private issuers
16/8/202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/8/202414:00PRNUSCASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2024 BUSINESS..
14/8/202412:18EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/7/202423:30PRNUSCASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS..
19/7/202412:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/7/202413:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/7/202413:30PRNUSCASI Pharmaceuticals announces appointment of Daniel Lang,..
26/6/202422:15PRNUSCASI Pharmaceuticals Announces Plan To Submit IND..
26/6/202422:10PRNUSCASI Pharmaceuticals Announces $15 Million Private Placement..
15/5/202414:00PRNUSCASI Pharmaceuticals Receives FDA Clearance On The..
15/5/202412:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/5/202414:00PRNUSCASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2024 BUSINESS..
08/4/202423:00PRNUSCASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS..
28/3/202412:00PRNUSCASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR..
Apertura: Min: Max:
Chiusura: 2,225

La tua Cronologia

NASDAQ
CASI
CASI Pharmaceuticals
USOTC
AMCCF
Amcor Plc CDI (PK)
NASDAQ
EXPO
Exponent
NASDAQ
SAFM
Sanderson Farms
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci